Ridgewood, NJ, United States of America

Milos Cejkov

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Milos Cejkov: Innovator in Protein Measurement Technologies

Introduction

Milos Cejkov is a notable inventor based in Ridgewood, NJ (US). He has made significant contributions to the field of protein measurement, particularly in the area of post-translational modifications. His innovative approach has the potential to enhance the accuracy of protein quantification, which is crucial in various scientific and medical applications.

Latest Patents

Milos Cejkov holds a patent titled "Heavy peptide approach to accurately measure unprocessed C-terminal lysine." This patent provides a method for accurately measuring post-translational modifications in proteins, such as antibodies. The method utilizes heavy isotopic standards to generate a calibration curve, allowing for precise quantitation of modified peptides. This technique is particularly useful for quantifying C-terminal truncation in antibodies using mass spectrometry.

Career Highlights

Milos Cejkov is currently employed at Regeneron Pharmaceuticals, Inc., where he applies his expertise in protein measurement technologies. His work at Regeneron has positioned him as a key player in the development of innovative solutions for protein analysis.

Collaborations

Milos collaborates with talented individuals such as Tyler Greer and Reid O'Brien Johnson. These collaborations enhance the research and development efforts at Regeneron Pharmaceuticals, contributing to advancements in the field.

Conclusion

Milos Cejkov's contributions to protein measurement technologies exemplify the impact of innovative thinking in scientific research. His patent and work at Regeneron Pharmaceuticals highlight the importance of accurate protein quantification in advancing medical and scientific knowledge.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…